Understanding Motor Neurone Disease
... experience cramps. As the disease progresses, limbs become less mobile and require extra care. Try gentle massage on the affected areas and keep them warm until the pain subsides. Gently moving the affected limb can relieve stiffness and joint pain. Joint problems: Muscle weakness can put strain on ...
... experience cramps. As the disease progresses, limbs become less mobile and require extra care. Try gentle massage on the affected areas and keep them warm until the pain subsides. Gently moving the affected limb can relieve stiffness and joint pain. Joint problems: Muscle weakness can put strain on ...
Anthrax Vaccine Program - Corporate-ir
... are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forwardlooking statements, including whether any product candidates will be shown to be safe and efficacious in clinical trials and the risks set forth in the company’s filings wit ...
... are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forwardlooking statements, including whether any product candidates will be shown to be safe and efficacious in clinical trials and the risks set forth in the company’s filings wit ...
Disease Eradication
... infected (Fig 1B). Patients may exhale virus for a week and shed virus in feces for a month, beginning just before symptoms develop, 7 to 14 days after they are infected. Persons who recover are then immune to the viral type that infected them (poliovirus 1, 2, or 3). Vaccination to prevent infectio ...
... infected (Fig 1B). Patients may exhale virus for a week and shed virus in feces for a month, beginning just before symptoms develop, 7 to 14 days after they are infected. Persons who recover are then immune to the viral type that infected them (poliovirus 1, 2, or 3). Vaccination to prevent infectio ...
403.3E1 Page 1 of 4 HEPATITIS B VACCINE INFORMATION AND
... Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV) which causes death in 1-2% of those infected. Most people with HBV recover completely, but approximately 5-10% become chronic carriers of the virus. Most of these people have no symptoms, but can continue to transmit the disease ...
... Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV) which causes death in 1-2% of those infected. Most people with HBV recover completely, but approximately 5-10% become chronic carriers of the virus. Most of these people have no symptoms, but can continue to transmit the disease ...
Word - Marion Independent School District
... Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV) which causes death in 1-2% of those infected. ...
... Hepatitis B is a viral infection caused by the Hepatitis B virus (HBV) which causes death in 1-2% of those infected. ...
DENGUE FEVER & DHF
... Infection caused by a virus and spread by an insect vector – the mosquito ...
... Infection caused by a virus and spread by an insect vector – the mosquito ...
Guillain-Barré Syndrome
... Between 50% and 60% of cases occur a few days to a few weeks after an infection. These infections include the common cold, sore throat, infectious mononucleosis, and viral hepatitis. GBS may also follow infections with stomach and intestinal viruses or bacteria that cause vomiting and diarrhea. Othe ...
... Between 50% and 60% of cases occur a few days to a few weeks after an infection. These infections include the common cold, sore throat, infectious mononucleosis, and viral hepatitis. GBS may also follow infections with stomach and intestinal viruses or bacteria that cause vomiting and diarrhea. Othe ...
History and aims of immunisation
... The National Immunisation Advisory Committee (NIAC) The Department of Health and Children (DoHC) The Health Service Executive (HSE) The National Immunisation Office (NIO) The Health Protection Surveillance Centre (HPSC) ...
... The National Immunisation Advisory Committee (NIAC) The Department of Health and Children (DoHC) The Health Service Executive (HSE) The National Immunisation Office (NIO) The Health Protection Surveillance Centre (HPSC) ...
Biological Disaster (Epidemics in India)
... We shall now discuss about polio myelitis, often called polio or infantile paralysis, is an infectious disease caused by the polio virus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as; fever, headache, vomiting, diarrhea, neck stiffn ...
... We shall now discuss about polio myelitis, often called polio or infantile paralysis, is an infectious disease caused by the polio virus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as; fever, headache, vomiting, diarrhea, neck stiffn ...
ACIP Updates February 2017
... persons identified as at ongoing increased risk because of a serogroup B meningococcal disease outbreak based on a minimum interval since their last MenB dose (interval to be further discussed) ...
... persons identified as at ongoing increased risk because of a serogroup B meningococcal disease outbreak based on a minimum interval since their last MenB dose (interval to be further discussed) ...
Childhood immunisations
... In general, children who are immunosuppressed should not receive live vaccines. Children who are immunosuppressed include those: • whose immune system does not work properly because they are undergoing treatment for a serious condition such as a transplant or cancer; or • who have any c ...
... In general, children who are immunosuppressed should not receive live vaccines. Children who are immunosuppressed include those: • whose immune system does not work properly because they are undergoing treatment for a serious condition such as a transplant or cancer; or • who have any c ...
Immunisation for babies
... contacts through soiled nappies for at least 14 days. However, vaccination of the baby will offer protection from rotavirus disease to those contacts, even those whose immune systems are weakened because of a medical condition or treatment, and outweighs any potential risk. All those in close contac ...
... contacts through soiled nappies for at least 14 days. However, vaccination of the baby will offer protection from rotavirus disease to those contacts, even those whose immune systems are weakened because of a medical condition or treatment, and outweighs any potential risk. All those in close contac ...
Human Papillomavirus (HPV) - Region of Waterloo Public Health
... HPV is commonly spread during sexual activity by skin to skin contact with an infected person. Most people never develop symptoms and do not know that they have been infected with HPV. They can still however carry the virus and infect others. Many HPV infections are transient. That is, the body’s im ...
... HPV is commonly spread during sexual activity by skin to skin contact with an infected person. Most people never develop symptoms and do not know that they have been infected with HPV. They can still however carry the virus and infect others. Many HPV infections are transient. That is, the body’s im ...
VIRUS
... The virus enters the respiratory tract in airborne droplets. Viremia is rare. Virus is present in the nasopharynx from 1-2 days before to 1-2 days after onset of symptoms. Inflammation of the upper respiratory tract causes necrosis of the ciliated and goblet cells of the tracheal and bronchial mucos ...
... The virus enters the respiratory tract in airborne droplets. Viremia is rare. Virus is present in the nasopharynx from 1-2 days before to 1-2 days after onset of symptoms. Inflammation of the upper respiratory tract causes necrosis of the ciliated and goblet cells of the tracheal and bronchial mucos ...
Ebola vaccine 2014: remained problems to be answer
... the interest on vaccine development by the main pharmaceutical company of the world might not be much at the early phase of outbreak. For sure, many tropical infectious diseases in poor tropical countries usually get less interest on funding and researching for vaccine development by pharmaceutical ...
... the interest on vaccine development by the main pharmaceutical company of the world might not be much at the early phase of outbreak. For sure, many tropical infectious diseases in poor tropical countries usually get less interest on funding and researching for vaccine development by pharmaceutical ...
Central nervous system infections
... Numerous arthropod-borne togaviruses can cause meningitis or encephalitis sometimes cause outbreaks of infection In different parts of the world, different mammals, birds or even reptiles act as reservoirs and there are a variety of arthropod (mosquito and tick) vectors. Usually, <1% of huma ...
... Numerous arthropod-borne togaviruses can cause meningitis or encephalitis sometimes cause outbreaks of infection In different parts of the world, different mammals, birds or even reptiles act as reservoirs and there are a variety of arthropod (mosquito and tick) vectors. Usually, <1% of huma ...
March/April 2000: Volume 28, Number 2 (PDF: 108KB/8 pages)
... DTP, DTaP, or DT. Subsequent routine Td boosters are recommended every 10 yrs. 3. Haemophilus influenzae type b (Hib): Three Hib conjugate vaccines are licensed for infant use. If PRP-OMP (PedvaxHIB or COMVAX from Merck) is given at 2 and 4 mos of age, a dose at 6 mos is not required. DTaP/Hib combi ...
... DTP, DTaP, or DT. Subsequent routine Td boosters are recommended every 10 yrs. 3. Haemophilus influenzae type b (Hib): Three Hib conjugate vaccines are licensed for infant use. If PRP-OMP (PedvaxHIB or COMVAX from Merck) is given at 2 and 4 mos of age, a dose at 6 mos is not required. DTaP/Hib combi ...
Diphtheria, Tetanus and Acellular Pertussis (Tdap) Vaccine
... Diphtheria is a serious disease of the nose, throat and skin. It is passed to others through coughing and sneezing. It causes sore throat, fever and chills. It can lead to breathing problems, heart failure and nerve damage. Treatment for diphtheria includes an antitoxin, followed by antibiotics. How ...
... Diphtheria is a serious disease of the nose, throat and skin. It is passed to others through coughing and sneezing. It causes sore throat, fever and chills. It can lead to breathing problems, heart failure and nerve damage. Treatment for diphtheria includes an antitoxin, followed by antibiotics. How ...
staff-presentation
... – difficulty accessing healthcare services – socioeconomic situation • Can put high community vaccination levels at risk ...
... – difficulty accessing healthcare services – socioeconomic situation • Can put high community vaccination levels at risk ...
INTRODUCTION - Aspenbloom Pet Care
... symptoms (indeed, only a tiny percentage of a population need develop symptoms for an epidemic to be declared). Thus, if a vaccinated individual is exposed to a disease and doesn’t get sick, it is impossible to know whether the vaccine worked, because there is no way to know if that person would hav ...
... symptoms (indeed, only a tiny percentage of a population need develop symptoms for an epidemic to be declared). Thus, if a vaccinated individual is exposed to a disease and doesn’t get sick, it is impossible to know whether the vaccine worked, because there is no way to know if that person would hav ...
The Case for Childhood Immunization
... About 26 percent of children (almost 34 million infants each year) still do not have access to basic immunization services, with lowest coverage in sub-Saharan Africa. In some countries, almost half the children have never received a single vaccine. In countries without adequate facilities to care f ...
... About 26 percent of children (almost 34 million infants each year) still do not have access to basic immunization services, with lowest coverage in sub-Saharan Africa. In some countries, almost half the children have never received a single vaccine. In countries without adequate facilities to care f ...
Novel FMD vaccine research in China
... vaccine has a satisfactory immune responses and protected from challenge. ¾ Contains all protective epitopes present on inactivated vaccine but lacks infectious viral nucleic acid and NSP. ¾ Allows to distinguish vaccinated animal from infected animals using NSP diagnostic tests. ¾ Can be safely pro ...
... vaccine has a satisfactory immune responses and protected from challenge. ¾ Contains all protective epitopes present on inactivated vaccine but lacks infectious viral nucleic acid and NSP. ¾ Allows to distinguish vaccinated animal from infected animals using NSP diagnostic tests. ¾ Can be safely pro ...
How Well Do Vaccines Work?
... the vaccine develop antibodies and if fewer people get sick with the disease (Qin et. al., 2007, p.13091310). For example (see Table 1), 96% to 99% of people who get the chickenpox vaccine develop antibodies to chickenpox (PHAC, 2006, p. 329), but studies have found that the vaccine is 70% to 90% ef ...
... the vaccine develop antibodies and if fewer people get sick with the disease (Qin et. al., 2007, p.13091310). For example (see Table 1), 96% to 99% of people who get the chickenpox vaccine develop antibodies to chickenpox (PHAC, 2006, p. 329), but studies have found that the vaccine is 70% to 90% ef ...
unit 11: diseases caused by faecal contamination
... Section 1: Overview of Faecal-Oral Diseases As the name suggests, faecal-oral diseases are diseases that occur when the causative organisms which are excreted in the stools of infected persons (or less commonly animals) gain entry into the human host via the mouth. Therefore, the organisms have to ...
... Section 1: Overview of Faecal-Oral Diseases As the name suggests, faecal-oral diseases are diseases that occur when the causative organisms which are excreted in the stools of infected persons (or less commonly animals) gain entry into the human host via the mouth. Therefore, the organisms have to ...
a historical review of the Measles virus, vaccine and outbreaks
... "My suspicion, which is shared by others in my profession, is that the nearly 10,000 SIDS deaths that occur in the United States each year are related to one or more of the vaccines that are routinely given children. The pertussis vaccine is the most likely villain, but it could also be one or more ...
... "My suspicion, which is shared by others in my profession, is that the nearly 10,000 SIDS deaths that occur in the United States each year are related to one or more of the vaccines that are routinely given children. The pertussis vaccine is the most likely villain, but it could also be one or more ...
Poliomyelitis
Poliomyelitis, often called polio or infantile paralysis, is an infectious disease caused by the poliovirus. Approximately 90% to 95% of infections cause no symptoms. Another 5 to 10% of people have minor symptoms such as: fever, headache, vomiting, diarrhea, neck stiffness and pains in the arms and legs. These people are usually back to normal within one or two weeks. In about 0.5% of cases there is muscle weakness resulting in an inability to move. This can occur over a few hours to few days. The weakness most often involves the legs but may less commonly involve the muscles of the head, neck and diaphragm. Many but not all people fully recover. In those with muscle weakness about 2% to 5% of children and 15% to 30% of adults die. Years after recovery post-polio syndrome may occur, with a slow development of muscle weakness similar to what the person had during the initial infection.Poliovirus is usually spread from person to person through infected feces entering the mouth. It may also be spread by food or water containing human feces and less commonly from infected saliva. Those who are infected may spread the disease even if no symptoms are present for up to six weeks. The disease may be diagnosed by finding the virus in the feces or detecting antibodies against it in the blood.The disease is preventable with the polio vaccine; however, a number of doses are required for it to be effective. The United States Center for Disease Control recommends polio vaccination boosters for travelers and those who live in countries where the disease is occurring. Once infected there is no specific treatment. In 2013 polio affected 416 people down from 350,000 cases in 1988. In 2014 the disease was only spreading between people in Afghanistan, Nigeria, and Pakistan. In 2015 wild polio was eliminated in Nigeria.Poliomyelitis has existed for thousands of years, with depictions of the disease in ancient art. The disease was first recognized as a distinct condition by Michael Underwood in 1789 and the virus that causes it was first identified in 1908 by Karl Landsteiner. Major outbreaks started to occur in the late 19th century in Europe and the United States. In the 20th century it became one of the most worrying childhood diseases in these areas. The first polio vaccine was developed in the 1950s by Jonas Salk. It is hoped that vaccination efforts and early detection of cases will result in global eradication of the disease by 2018. In 2013; however, there were reports of new cases in Syria and in May 2014, the World Health Organization declared a public health emergency of international concern due to outbreaks of the disease in Asia, Africa and the Middle East. The disease does not naturally occur in any other animals.